NCT05509725View on ClinicalTrials.gov

Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)

PHASE4RecruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

August 11, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
IBS - Irritable Bowel Syndrome
Interventions
DRUG

Probiotic formulation

Participants will be asked to take 2 doses daily

DRUG

Placebo

Participants will be asked to take 2 doses daily

Trial Locations (1)

35040

RECRUITING

Ege University Faculty of Medicine, Gastroenterology Department, Izmir

Sponsors
All Listed Sponsors
lead

Lallemand Health Solutions

INDUSTRY